(Z)-Ethyl 3-(pyrrolidin-1-yl)but-2-enoate, 95.0%, 1g

N-ETHYLSUCCINIMIDE, 95.0%, 5g

GC capillary column ROTI®Cap-1, 50 m, 0.32 mm, 0.10 µm, 1 Piece(s)

5-Methyl-3-phenyl-2-thioxoimidazolidin-4-one, 98%, 5g

6-CHLORO-N3-METHYLPYRIDAZINE-3,4-DIAMINE, 98.0%, 5g

3,4-Dihydro-2H-isoquinoline-1-thione, 95.0%, 1g

2-[(1R*,4R*)-4-Aminocyclohexyl]-7-fluoroisoindolin-1-one hydrochloride, 1g

8-Oxa-2-azaspiro[4.5]decan-3-one, 95.0%, 250mg

2-MORPHOLINE-4,6-DIFLUOROPYRIMIDINE, 97.0%, 10g

2-(tetrahydro-3-furanyl)ethanamine, 95.0%, 1g

(R)-1-phenylethanamine (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, 97%, 5g

Histamine Dihydrochloride>98.0%(HPLC)(T)5g

5-Chloro-3-(4-fluorophenyl)isoxazole, 5g